Shattuck Labs, Inc.
NASDAQ:STTKBiotechnology
Healthcare
$4.55 +2.33%
+$0.11 today
- Market cap
- $463.38M
- Beta
- 1.09
- P/E (TTM)
- -10.9
- EPS (TTM)
- -$0.44
52W Low $0.71High $8.33
Volume 1.39M
Average 0.69M
Income Statement
Follow revenue through to earnings.
Revenue
$1.00M
FY 2025 · Annual
-82.5% YoYOperating Income
-$51.51M
FY 2025 · Annual
Net Income
-$48.81M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 30.02M | 652K | 1.66M | 5.72M | 1M |
| Cost of Revenue | 1.38M | 82.2M | 4.04M | 4.89M | 0 |
| Gross Profit | 28.64M | (81.55M) | (2.39M) | 827K | 1M |
| Gross Margin | 95.4% | -12507.2% | -143.9% | 14.5% | 100.0% |
| Research & Development | 56.56M | 82.9M | 74.31M | 67.21M | 35.27M |
| Selling, General & Admin | 18.72M | 19.68M | 19.3M | 19.08M | 17.24M |
| Operating Expenses | 73.91M | 21.78M | 89.57M | 81.39M | 52.51M |
| Depreciation & Amortization | 1.38M | 3.07M | 4.04M | 3.83M | 3.69M |
| EBITDA | (43.59M) | (98.87M) | (83.26M) | (71.58M) | (45.12M) |
| EBITDA Margin | -145.2% | -15164.4% | -5024.5% | -1251.2% | -4512.1% |
| Operating Income | (45.27M) | (103.33M) | (91.96M) | (80.57M) | (51.51M) |
| Operating Margin | -150.8% | -15848.0% | -5549.6% | -1408.3% | -5150.8% |
| Interest Income | 625K | 1.59M | 4.67M | 5.17M | 2.7M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 295K | 1.38M | 4.66M | 5.16M | 2.7M |
| Income Before Tax | (44.97M) | (101.95M) | (87.3M) | (75.41M) | (48.81M) |
| Pre-Tax Margin | -149.8% | -15635.7% | -5268.4% | -1318.1% | -4880.9% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (44.97M) | (101.95M) | (87.3M) | (75.41M) | (48.81M) |
| Net Margin | -149.8% | -15635.7% | -5268.4% | -1318.1% | -4880.9% |
| EPS (Basic) | (1.07) | (2.41) | (2.05) | (1.49) | (0.70) |
| EPS (Diluted) | (1.07) | (2.41) | (2.05) | (1.49) | (0.70) |
| 42.03M | 42.38M | 42.6M | 50.76M | 69.58M | |
| 42.03M | 42.38M | 42.6M | 50.76M | 69.58M |
STTK Earnings Waterfall · TTM
NASDAQ:STTK · Revenue to Net Income
Key Ratios
EPS$-0.63
Gross Margin25.0%
Net Margin-251.4%
P/E Ratio-6.2
P/S Ratio43.1
Analysis
$1.0M of revenue converted into -$49.9M of net income for the selected period. Gross margin is 25.0% and net margin is -251.4%, showing how much revenue survives after costs and taxes. EPS is $-0.63, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 5, 2026 | |
| 10-Q | Quarterly report | Nov 5, 2026 | |
| SC 13G | SC 13G filing | Oct 27, 2026 | |
| SC 13G/A | SC 13G/A filing | Aug 14, 2026 | |
| 10-Q | Quarterly report | Aug 11, 2026 |
How much revenue does STTK generate?
Shattuck Labs, Inc. (STTK) reported $1.00M of revenue in fiscal 2025.
Is STTK profitable?
Shattuck Labs, Inc. (STTK) reported -$48.81M of net income, with a net margin of -4880.9%.
Continue the stock analysis
Jump to another research area for this company.